Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Accumulated Expenses (2016 - 2025)

GeoVax Labs (GOVX) has disclosed Accumulated Expenses for 15 consecutive years, with $1.3 million as the latest value for Q4 2024.

  • On a quarterly basis, Accumulated Expenses changed N/A to $1.3 million in Q4 2024 year-over-year; TTM through Dec 2024 was $1.3 million, a N/A change, with the full-year FY2024 number at $1.3 million, changed N/A from a year prior.
  • Accumulated Expenses was $1.3 million for Q4 2024 at GeoVax Labs, down from $1.4 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $3.4 million in Q4 2021 to a low of $36623.0 in Q1 2021.
  • A 5-year average of $1.4 million and a median of $1.3 million in 2024 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: plummeted 98.09% in 2021, then soared 8296.36% in 2022.
  • GeoVax Labs' Accumulated Expenses stood at $359281.0 in 2020, then soared by 840.16% to $3.4 million in 2021, then fell by 8.97% to $3.1 million in 2022, then rose by 5.73% to $3.3 million in 2023, then tumbled by 61.32% to $1.3 million in 2024.
  • Per Business Quant, the three most recent readings for GOVX's Accumulated Expenses are $1.3 million (Q4 2024), $1.4 million (Q1 2024), and $3.3 million (Q1 2023).